Introduction
Cancer-related pain (CRP) remains one of the most distressing symptoms for cancer patients and survivors, leading to significant functional disability and a negative impact on quality of life. 1 , 2 Pain affects an estimated 55% of persons during anticancer treatment, up to 66% of individuals with advanced cancer, 2 , 3 and persists in half of cancer survivors after the completion of treatment. 4 Pain has long been recognized as one of the most common reasons for emergency care 5 and cancer patient hospitalizations, and currently accounts for up to 28% of unplanned and potentially preventable hospitalizations. 6 Both pain specialists and cancer communities recognize a significant need for pain control that is effective and well tolerated and for multimodal therapies to reduce not only suffering from pain but also subsequent hospital admissions for pain control.
Clinical guidelines advocate nonpharmacologic therapies and self-management (SM) of chronic pain, 7 - 9 but nonpharmacologic and SM options for CRP are challenging for providers and patients alike. Acupuncture is included in the current guidelines for chronic pain 10 , 11 and, as of 2020, is covered by Medicare. 12 Auricular acupuncture (also called battlefield acupuncture) 13 , 14 using the ear acupoints is easier to learn and administer than body acupuncture. 15 The Department of Defense and Veterans Affairs (VA) developed a curriculum of auricular acupuncture to train over 2700 VA providers with pain management responsibilities since 2016. 16 Despite these advances, widespread implementation is hindered by frequent office visits, high costs, patients’ misconceptions, and a lack of access to licensed acupuncturists. 17 , 18
Auricular point acupressure (APA) is the application of acupuncture-like stimulation to specific points on the ear (acupoints). In APA, small pellets (2 mm in diameter) are taped on specific ear points, and patients press on the pellets to stimulate the ear points 3 times daily, 3 minutes per time, for a total of 9 minutes per day ( Figure 1 ). 19 , 20 APA is a noninvasive (needleless) and active treatment for patients with pain, whereas acupuncture is invasive (using needles) and a passive treatment (administered by a licensed practitioner). 21 , 22

Accumulated extensive evidence has demonstrated the effects of APA on pain. 23 - 26 Evidence of APA as pain relief points to several potential biological mechanisms: (1) direct (ie, stimulation of trigeminal and vagus nerve innervation distributed on the ear) or indirect effects (eg, ear point stimulation as a conscious behavior) 27 , (2) modulation of inflammatory cytokine levels (decreased proinflammatory cytokines [IL-1β, IL-6, TNF-α]) or stimulation to release anti-inflammatory cytokines (IL-13 and IL-4) in the peripheral serum 19 , 28 - 30 , and (3) modulation of nerve sensitivity, transmitting APA stimuli into neuronal signals to modulate pain in the central nervous system. 29
Nurses are the patient’s first line of support in managing inpatient CRP; however, nurses have limited tools to deliver this support. To address this dilemma, patients and nurses need access to a therapy that can quickly relieve pain, which, in turn, reduces analgesic use and encourages patients to engage in other pain interventions. APA is one possible solution for unmet challenges in CRP management.
Although patients with pain are interested in complementary and integrative management approaches, 31 , 32 clinicians’ lack of knowledge sometimes limits their use. Thus, due to the noninvasive characteristics of APA, we assessed the feasibility of providing an APA training workshop for clinical oncology nurses to integrate APA into real-world nursing care settings. We hypothesized that nurses could learn APA and incorporate it into their practice to provide pain relief. The aims of this study were to (1) examine the feasibility of providing an APA training course for clinical oncology nurses to integrate APA into real-world nursing care settings and (2) examine the effectiveness of APA on CRP under usual inpatient oncology ward conditions.
Research Design and Methods
A 2-phase feasibility study was used to examine the effectiveness of an APA training course for nurses that can be integrated into real-world clinical settings to manage CRP. All human subject procedures were approved by the Johns Hopkins Medicine Institutional Review Board (IRB00183805: approved date: 10/08/2019).
Phase 1—Training
In collaboration with a Comprehensive Cancer Center in Maryland, USA, an APA training course was provided to 10 nurses who worked with oncology patients. After a written inform consent was signed, nurses completed the APA training, which included 5 hours of didactic presentations and 3 hours of personal hands-on training, to ensure a deeper understanding of APA and how to integrate it into nursing practice. At the conclusion of training, nurses received a completion certificate upon passing the examination and 7.2 continuing education credit hours.
Participants
Oncology nurses practicing at a Comprehensive Cancer Center in Maryland, USA signed a written informed consent, and received approval from their supervisors to attend the training workshop. Ten oncology nurses (8 females and 2 males) completed the APA training.
Workshop (APA Training)
The course included 5 hours of didactic presentations and 3 hours of personal hands-on training, to ensure a deep understanding of APA. The didactic training comprised content derived from textbooks, articles, and websites, presented in 5 lectures: (1) overview and theoretical perspective of auricular therapy, (2) anatomical terminology for the external ear, (3) auricular master points, musculoskeletal and sensory ear points, (4) auricular diagnosis and treatment procedures, and (5) commonly used APA protocols for CRP. For the hands-on training, learning was reinforced through immersive learning, demonstration, and return-demonstration. Nurses practiced identifying the appropriate ear points by placing a pin on silicone ear models. Then they practiced using a probe to identify the ear points on selected area of CRP and placing APA seeds on a nurse volunteer while being observed and mentored by the APA educator (Yeh). To successfully complete the practicum course, the nurses had to demonstrate APA competency via a skills checklist, including the use of the probe to find the points corresponding to body pain, seed placement, and stimulation of the ear points.
Measures
Knowledge of APA treatment
An assessment to examine the nurses’ knowledge of APA was developed by the team, based on the APA workshop content (the test is available upon request). The knowledge test consisted of 43 multiple choice questions and 7 open-ended questions (the score ranged from 0 to 100, with 100 indicating a perfect score). Questions covered the theoretical perspective of auricular therapy, anatomical terminology for the external ear related to the body, auricular diagnosis procedures to locate the ear points, master points of the treatment effects, musculoskeletal and sensory ear points, and how to stimulate the ear points.
Confidence scale to practice APA
Nurses’ confidence in practicing APA was assessed before and after the training via a self-report measure comprising 1 item adapted from the Confidence Scale 33 : Overall how confident are you that you are able to practice APA successfully? The item was measured via a 10-point Likert scale ranging from 0 (not at all confident) to 10 (extremely confident).
Practice treatment log
After completing the training workshop, each nurse was required to submit a treatment log for 5 friends or peers in order to receive APA practitioner certification. The log included the body map to mark the pain location, auricular photos marking the points for treatment, pain details (descriptions from the participants), and the pain intensity (0-10 scale) before APA, immediately after APA, and 24 and 48 hours post-APA treatment.
Results
Feasibility of APA training and training outcomes
We found that delivering an 8 hour training to nurses for APA mastery was feasible. The mean score on the post-course APA knowledge test was 93% (standard deviation [SD] = 6.87). The mean score on the measure of confidence in APA practice increased from 0 before the workshop to 6.5 (SD = 0.84, range 5-10) after the workshop.
Table 1 presents the pain outcomes in the practice treatment log after nurses received APA training and practiced APA treatment on 5 friends or peers. A total of 44 people received APA treatment during the practice. These individuals reported an average 49% decrease in pain intensity immediately after APA, an average 60% decrease 1-day post-APA, and an average 66% decrease 2 days post-APA.
Table 1.
Summary Statistics of Pain Intensity from Practice Logs for Practice After APA Training.
Abbreviation: SD, standard deviation. a =100 × (post APA visit-pre APA)/pre APA.
| Pre APA mean (SD) (min, max) | Immediately post APA mean (SD) (min, max) | Day 1 post APA mean (SD) (min, max) | Day 2 post APA mean (SD) (min, max) | |
| Pain intensity | 4.8 (1.67) (2, 9) | 2.5 (1.69) (0, 5) | 1.6 (1.15) (0, 4) | 1.4 (1.45) (0, 5) |
| Change from Pre APA | −2.3 (1.58) (−6.0, 0.0) | −3.2 (2.14) (−7.5, 1.0) | −3.4 (2.23) (−7.5, 1.0) | |
| % (Min, Max) a | −49 (−100, 0) | −60 (−100, 50) | −66 (−100, 50) |
After the training, APA was added as a non-pharmacological intervention in the hospital electronic health records (EHRs), so that the nurses could document the implementation of APA for CRP management.
Phase 2—Implementation
After receiving APA certification, nurses implemented APA for CRP as part of their nursing care activities. This involved teaching the consented patients about APA and their role in stimulating the seeds by evenly pressing on each seed without rubbing for 3 minutes, 3 times daily (9 minutes total). All patients provided written informed consent before receiving the APA for CRP. The study outcomes were assessed at 4 time points: pre-intervention and daily for up to 3 days either in person for those who were still hospitalized or via phone call for those who had been discharged. The assessments were scheduled according to the patients’ preference. Pain medication was not withheld from the patients, as APA treatment was an addition to prescribed medications.
Participants (Patients)
Patients were eligible to participate if they were (1) cancer patients whose worst pain was rated as ≥4 on a 0 to 10 numeric rating scale in the past 24 hours, which was assessed using the Brief Pain Inventory—Short Form (BPI-sf), 34 (2) able to read and write English, and (3) able to apply pressure to the seeds taped to the ears. Patients were excluded if they (1) were delirious, (2) had ear skin disease, or (3) were allergic to the latex tape used in the study.
Recruitment
The team screened the EHR on the dedicated oncology units to identify patients with a pain intensity ≥4 (0-10 scale). They then obtained consent from the patients, and the nurse was directed to provide the APA treatment. Patients were eligible if they were inpatients and agreed to undergo APA treatment for their CRP. Patients were excluded if they (1) were delirious, (2) had ear skin disease, or (3) were allergic to the tape used for this study. Initially, each APA-trained nurse was expected to treat 20 patients (200 total patients) from within their assigned patients within 6 months. However, mandatory COVID-19 restrictions ended the study before this could be done. Only 33 participants were included in this report.
Measurement
Symptom severity assessment and APA practice
A daily survey link was sent to the patient via text message to collect (1) symptom severity (pain, fatigue, and sleep disturbance) on a scale ranging from 0 (not present) to 10 (as bad as you can imagine), (2) APA practice information (including frequency and duration of pressing the seeds taped to their ears and any side effects), and (3) pain medication use.
Qualitative interviews
Qualitative methods (individual in-depth interviews) were used to elicit nurses’ perspectives of the integration of APA into clinical practice and to identify barriers/facilitators to implementation. After APA had been implemented for 6 weeks, each nurse was contacted for an interview to assess the integration of APA into clinical practice to manage CRP and the nurses’ satisfaction with APA. Participants were interviewed based on their availability in a private setting of their choice. A trained interviewer conducted the semi-structured interviews, which began broadly with general questions, such as “Can you tell me how you feel when you implement APA to treat your patient’s pain?” Then, the interviewer gradually moved to aspects more directly related to nurses’ concerns, such as the challenges to providing APA for patients. The in-depth interviews ranged from 30 to 40 minutes. The interviews were audio recorded and transcribed for analysis.
Statistical Methods
Descriptive statistics were used to present demographic characteristics and study measures. For the nursing APA education outcomes, a paired t-test was used to examine the differences in confidence to practice APA to manage CRP from pre-training to post-training. For the severity of each symptom (pain intensity, fatigue, and sleep disturbance), the mean changes from pre-APA were analyzed using a linear mixed model that included categorical time points (day 1, day 2, day 3 post-APA) as fixed effects and random subject intercept. Due to the nature of self-report questionnaires and participant non-response, missing data were encountered in several variables of interest. Out of the initial sample of 33 participants, 8 participants did not complete the questionnaire in its entirety. Missing data were observed in the outcome measures, representing approximately 19.7% of the total dataset. The analysis was based on observed data (not imputed). The demographic characteristics were summarized for all enrolled patients, while the outcome measures were summarized for patients who received the treatment.
The restricted maximum likelihood method was used to estimate the variance, and an unstructured (co)variance was specified. The Kenward-Roger approximation was used to estimate denominator degrees of freedom. Significance tests were based on the generalized least squares means for the hypothesis of no change from pre-intervention at each time point with a significance level of α = .05. To determine which treatment variables might be associated with the primary outcomes, the mixed model for repeated measures was analyzed by including the continuous, fixed effects of the time each seed was pressed, press minutes, and press total, in addition to the categorical, fixed effects of time points. Milligram morphine equivalents (MME) were determined using established equivalency factors of all opioids taken by a participant daily. 35 For this pilot study, summary statistics (means, SDs, or medians) were emphasized over hypotheses testing.
Qualitative Data Analysis
Data analysis was guided by the techniques suggested by Miles and Huberman. 36 Qualitative content analysis was implemented to code responses (ie, line-by-line coding, constant comparative methods to analyze differences and similarities in responses, and construction of categories and themes). 36 A content analysis summary table was used to summarize similarities and differences in findings. The qualitative interviews were coded line by line, and data was separated based on differences and similarities into categories, which were separated into themes, analyzed, and coded. 36
Results
Participant characteristics
In total, 33 patients were recruited into the study and received APA treatments. Table 2 presents the demographic characteristics. The average age of the participants was 50.2 years (SD = 15.64, range 20-74). Among the 33 participants, the majority were White (n = 18, 55%) and men (n = 19, 58%). Cancer diagnoses included breast cancer (n = 9), colon cancer (n = 2), leukemia (n = 1), and other solid tumors (n = 21).
Table 2.
Demographic and Clinical Characteristics (N = 33).
Abbreviation: SD, standard deviation.
| Statistics | |
| Age, y mean (SD) (min, max) | 50.2 (15.64) (20, 74) |
| Gender, n (%) | |
| Female | 14 (42.4) |
| Male | 19 (57.6) |
| Race, n (%) | |
| Asian | 3 (9.1) |
| Black | 8 (24.2) |
| Other | 4 (12.1) |
| White | 18 (54.5) |
| Ethnicity, n (%) | |
| Hispanic | 2 (6.1) |
| Non-Hispanic | 30 (90.9) |
| Unknown | 1 (3.0) |
| Cancer diagnosis, n (%) | |
| Leukemia | 9 (27.3) |
| Brain cancer | 1 (3.0) |
| Breast cancer | 1 (3.0) |
| Cervical cancer | 1 (3.0) |
| Endocrine cancer | 3 (9.1) |
| GI cancer | 7 (21.2) |
| Multiple myeloma | 3 (9.1) |
| Myeloproliferative disease, polycythemia | 1 (3.0) |
| Osteosarcoma | 2 (6.1) |
| Prostate and testicular cancer | 2 (6.1) |
| Other solid tumor | 3 (9.0) |
Symptom severity
Table 3 shows summary statistics (mean and SD) for the study outcomes (pain, fatigue, and sleep disturbance) at pre-APA and daily post-APA for 3 days. For pain intensity, compared to pre-APA, the participants reported a 28% improvement at day 1 post-APA; they continued to improve and reached a 38% improvement at day 3 post-APA. For fatigue severity, participants reported 33% improvement at day 1 post-APA and reached 39% improvement at day 3 post-APA. For sleep disturbance, participants reported 44% improvement at day 1 post-APA and had 45% improvement at day 3 post-APA. All the improvements in pain intensity ( P < .05), fatigue ( P < .05), and sleep disturbance ( P < .05) were statistically significant, compared to pre-APA. Figure 2 shows the mean and 95% confidence interval of symptom changes on day 1, day 2 and day 3 post-APA among hospitalized oncology patients.
Table 3.
Summary Statistics for Study Outcomes.
a Percent change = 100 × (day post-APA–pre)/pre. *** P < .05.
| Primary outcome measures | Pre-APA | Day 1 post APA mean (SD) | Day 2 post APA mean (SD) | Day 3 post APA mean (SD) | |
| Pain intensity | Mean (SD) | 8.3 (1.57) | 5.9 (2.15) | 5.2 (2.39) | 5.0 (2.18) |
| Change from pre-APA | Mean (SD) (%) a | −2.5 (2.29) (−30) *** | −3.2 (2.74) (−36) *** | −3.4 (2.55) (−38) *** | |
| Fatigue | Mean (SD) | 7.0 (1.91) | 4.5 (2.49) | 3.9 (2.67) | 3.9 (2.50) |
| Change from pre-APA | Mean (SD) (%) a | −2.6 (2.90) (−38) | −3.2 (3.18) (−41) | −3.1 (3.09) (−39) | |
| Sleep disturbance | Mean (SD) | 6.4 (2.69) | 3.8 (2.92) | 3.2 (2.31) | 3.6 (2.66) |
| Change from pre-APA | Mean (SD) (%) a | −2.9 (2.57) (−37) | −3.4 (2.38) (−32) | −3.1 (2.63) (−36) |

Pain medication use
Table 4 presents the use of pain medication (including the names of opioids). At pre-APA, 79% (n = 26) patients reported the use of pain medications, which reached a 24% decrease by day 3 post-intervention (55%, n = 18). Twenty-two patients (n = 67%) reported using at least one type of opioid at pre-APA, which reached a 19% decrease (48%, n = 16). MME dosages decreased from 110 mg at pre-APA to 101 mg after 3 days of APA.
Table 4.
Pain Medication Use.
The denominator used to estimate % change of “any type of opioid” was the total number of subjects (N = 33). Dosage was converted using the MME conversion factor with the subjects had available dosage for all 4 days. Abbreviations: SD, standard deviation; IQR, interquartile range. a n is less than the total N (33) due to missing data.
| Pre-APA | Day 1 post APA | Day 2 post APA | Day 3 post APA | |
| Pain medication (any type) | 26 (79%) | 20 (61%) | 20 (61%) | 18 (55%) |
| Any opioid | ||||
| n (%) of subjects | 22 (67) | 17 (52) | 17 (52) | 16 (48) |
| Dosage, mean (SD) | 87.35 (376.54) | 84.86 (375.68) | 84.64 (375.66) | 79.86 (375.44) |
| Dosage, median (IQR) (min, max) | 0 (12) (0, 2167.5) | 0 (8) (0, 2160) | 0 (8) (0, 2160) | 0 (8) (0, 2160) |
| Oxycodone | ||||
| n (%) of subjects | 10 (30) | 6 (18) | 7 (21) | 6 (18) |
| Dosage, mean (SD) | 5.39 (16.63) | 4.69 (16.69) | 4.45 (14.74) | 2.58 (10.71) |
| Dosage, median (IQR) (min, max) | 0 (0) (0, 75) | 0 (0) (0, 75) | 0 (0) (0, 60) | 0 (0) (0, 60) |
| Hydromorphone | ||||
| n (%) of subjects | 7 (21) | 4 (12) | 4 (12) | 4 (12) |
| Dosage, mean (SD) | 4.61 (16.71) | 4.48 (16.73) | 4.48 (16.73) | 4.48 (16.73) |
| Dosage, median (IQR) (min, max) | 0 (0) (0, 80) | 0 (0) (0, 80) | 0 (0) (0, 80) | 0 (0) (0, 80) |
| Morphine | ||||
| n (%) of subjects | 6 (18) | 4 (12) | 4 (12) | 3 (9) |
| Dosage, mean (SD) | 11.50 (41.04) | 10.32 (41.27) | 10.32 (41.27) | 7.66 (35.99) |
| Dosage, median (IQR) (min, max) | 0 (0) (0, 200) | 0 (0) (0, 200) | 0 (0) (0, 200) | 0 (0) (0, 200) |
| Fentanyl transdermal patch | ||||
| n (%) of subjects | 3 (9) | 4 (12) | 4 (12) | 4 (12) |
| Dosage, mean (SD) | 67.50 (381.84) | 69.68 (387.95) | 69.68 (387.95) | 69.68 (387.95) |
| Dosage, median (IQR) (min, max) | 0 (0) (0, 2160) | 0 (0) (0, 2160) | 0 (0) (0, 2160) | 0 (0) (0, 2160) |
| Tramadol a | ||||
| n (%) of subjects | 4 (12) | 1 (3) | 1 (3) | 1 (3) |
| Dosage, mean (SD) | 0.94 (5.30) | 0.00 (0.00) | 0.00 (0.00) | 0.00 (0.00) |
| Dosage, median (IQR) (min, max) | 0 (0) (0, 30) | 0 (0) (0, 0) | 0 (0) (0, 0) | 0 (0) (0, 0) |
| Codeine a | ||||
| n (%) of subjects | 0 (0) | 1 (3) | 1 (3) | 0 (0) |
| Dosage, mean (SD) | 0.00 (0.00) | 0.68 (3.92) | 0.68 (3.92) | 0.00 (0.00) |
| Dosage, median (IQR) (min, max) | 0 (0) (0, 0) | 0 (0) (0, 22.5) | 0 (0) (0, 22.5) | 0 (0) (0, 0) |
APA practice
Table 5 presents daily APA practice by the participants. The results indicate that participants pressed the seeds approximately 4 times per day (3 times suggested), >3 minutes per time (3 minutes suggested), and 10 minutes per day (9 minutes suggested). Participants exhibited an 100% adherence rate throughout 3 days post-APA. The side effects of APA were minimal (~8-12% felt some tenderness of the ear).
Table 5.
APA Practice and Adverse Effect.
Abbreviation: SD, standard deviation.
| Day 1 post | Day 2 post APA | Day 3 post APA | |
| Frequency to press the seed (times) mean (SD) | 3.9 (1.97) | 4.2 (2.35) | 4.2 (2.2) |
| Time to press seed per time (min) mean (SD) | 3.1 (1.81) | 3.1 (1.76) | 3.2 (1.88) |
| Time to press seed per d (min) mean (SD) | 10.2 (4.45) | 10.9 (5.21) | 10.6 (5.13) |
| Side effects of APA on the ear, n (%) | |||
| Tenderness | 2 (8%) | 2 (8%) | 3 (12%) |
Association between APA practice and symptom severity
Table 6 presents the results of the frequency of seed pressing per day (eg, number of times), the duration of each pressing time (minutes), and the duration of total pressing per day (minutes) on the primary outcomes, respectively (pain, fatigue, and sleep disturbance). The frequency of seed pressing was significantly associated with the changes in the score from pre-APA in pain ( P = .04) and fatigue ( P = .002), but was not significantly associated with the changes in the score in sleep disturbance ( P = .12); the duration of total pressing per day (minutes) on the ear was significantly associated with changes in the scores from pre-APA in fatigue ( P = .007) and sleep disturbance ( P = .007), but was not significantly associated with changes in the score for pain ( P = .31). The duration of each pressing time was not significantly associated with any of the 3 primary outcomes ( P > .05).
Table 6.
Relationship Between Treatment Variables and the Primary Outcomes.
Abbreviation: ref, baseline.
| Pain | Fatigue | Insomnia | ||||
| Likelihood ratio test, Chi-square = 65.78, df = 5, P < .001 | Likelihood ratio test, Chi-square = 65.75, df = 5, P < .001 | Likelihood ratio test, Chi-square = 83.98, df = 5, P < .001 | ||||
| Estimated coeff (SE) | P -value | Estimated coeff (SE) | P -value | Estimated coeff (SE) | P -value | |
| Frequency of seed pressing per d | 0.56 (0.265) | .04 | 1.05 (0.304) | .002 | 0.45 (0.276) | .12 |
| Duration of each pressing (min) | 0.27 (0.265) | .32 | 0.04 (0.274) | .89 | −0.06 (0.240) | .82 |
| Duration of total pressing per d (min) | −0.15 (0.14) | .31 | −0.48 (0.172) | .007 | −0.34 (0.120) | .007 |
| Day 1 | ref | ref | ref | |||
| Day 2 | −0.46 (0.277) | .11 | −0.31 (0.374) | .42 | 0.01 (0.213) | .95 |
| Day 3 | −0.49 (0.328) | .86 | −0.39 (0.361) | .29 | 0.21 (0.387) | .28 |
Qualitative finding (major themes)
Our interview data revealed 3 themes: time management, patient interest, and confidence.
Theme 1: Time management
This theme captured the nuances of time management for the nurses. They identified the time needed to administer the treatment as the biggest barrier. They felt more time was available on the night shift, but at that time, the patients were sleeping. A few nurses noted that patients needed time to think about agreeing to the intervention and they had a “hard time selling it to the patient.”
Theme 2: Patient interest
The nurses found that patient interest varied, as some patients were skeptical, but most were intrigued by a different treatment option. They also noted that some patients were just overwhelmed with treatment altogether and that considering APA was difficult. One nurse said, “Some people are more open and others are like ‘I want to think about it.’”
Theme 3: Confidence
All of the nurses reported that their confidence in providing APA increased after the training but greatly increased after practice. Some nurses noticed improvement in finding the tender points on the ears and their confidence increased when patients were happy with the treatments. The nurses who attended this training were enthusiastic about learning a new technique that they could provide independently to help control patients’ pain.
Discussion
To our knowledge, this is the first study to provide APA training to oncology nurses to be implemented in clinical practice to manage inpatients’ CRP. Our study findings indicate that it is feasible to provide an 8-hour workshop for the oncology nurses to learn APA and implement it in clinical nursing practice to manage CRP. The findings from the cancer patients who received APA treatment from the trained nurses are promising. APA in this pilot trial provided quick, sustained, inexpensive, and easily achieved relief, reflected in improvements in not only pain intensity, but also in fatigue and sleep disturbance. Unrelieved pain is a common occurrence in cancer patients and reduces quality of life and even lifespan, 37 , 38 and new methods need to be considered to treat it.
As a pilot trial designed to gather data to estimate an effect size for a randomized clinical trial, we found patients had achieved almost 40% pain relief, and improvement in fatigue and sleep disturbance within 3 days. Importantly, 24% of patients were able to decrease their pain medications and 19% were able to decrease opioids (less than 10 mg of MME dosages). Further research is clearly warranted to determine whether APA can be integrated into routine oncology inpatient practice.
We found that an 8 hour in-person workshop was sufficient to provide the required APA knowledge and skills. However, scheduling the workshop for 10 nurses was challenging due to their busy clinical responsibilities. To overcome the scheduling conflicts, a hybrid course including online asynchronous didactic presentations and hands-on training could be used to facilitate a deeper understanding of APA. The course could use modules with content presented through article and textbook readings, websites, and video streaming. Learning should be reinforced during in-person hands-on training through didactic approaches, immersive learning, demonstration, and discussions. The training should include required competency for delivering APA treatment, competency testing after the training, and maintaining competency.
To date, few interventions have addressed emerging CRP, fatigue, or insomnia during chemotherapy. 39 , 40 Hospitalized cancer patients in this study were able to adhere to the suggested APA practice. The side effects of the APA were minimal, that is, about 10% of the patients felt tenderness on the ear. The tenderness of the ear points are correlated to the severity of the body symptoms; for example, the greater pain intensity in the body, the more tenderness of the corresponding ear points. 21 Thus, it is important to inform patients of this correlation in the future. Given that healthcare providers have limited tools to help patients manage CRP, 41 , 42 APA has the potential to overcome barriers in pain management at multiple levels by empowering nurses to provide an additional safe, effective and rapid pain relieve intervention, while patients gain some control and ability to manage pain on their own.
Our qualitative findings suggested that the technique used in the APA workshop was successful as a beginning to build APA knowledge and skills. However, 1 barrier identified by nurses was finding time to actually provide the treatment during their shift. As we approach new and innovative ways to help our patients, we need to consider how interventions like APA can be incorporated into nurses’ daily workflow. Being able to document the application of APA in the EHRs will enable tracking ability and providing APA to clinicians as one of alternative options for symptoms relief.
The study was limited by the sample size, which was smaller than the intended sample size due to COVID-19 in-person contact restrictions. Due to the nature of our study, participants were not blinded so potential bias can be a concern and the time for each nurse to administer the APA for a patient was not observed.
We conclude that APA is an ideal tool for training healthcare professionals to provide treatments for patients with pain. APA is a scalable treatment that would benefit from further evidence from a pragmatic controlled trial to evaluate the effectiveness of APA embedded in routine care. We believe that replicating this study in a randomized clinical trial with a larger sample is the next step to confirm the efficacy of APA for treating CRP in real-world practice for oncology nurses.
Research reported in this publication was supported by the Brager Humanitarian Award at the Johns Hopkins Kimmel Cancer Center and an Under Armour Women’s Health & Breast Cancer Innovation Grant, Johns Hopkins Medicine. Funding sources were not involved in the preparation, writing, or submission of this paper. It is with heavy hearts and profound sadness that we acknowledge the untimely passing of our esteemed coauthor, Professor Dr. Chao Hsing Yeh. Tragically, Dr. Yeh passed away during the final stages of manuscript submission, leaving an immeasurable void in our hearts and in the scientific community. Throughout the course of this project, Dr.Yeh demonstrated an exceptional commitment to excellence, pushing the boundaries of our understanding and challenging us to achieve new heights. Her insightful perspectives, innovative ideas, and meticulous attention to detail significantly enhanced the quality of this work. The authors would like to thank the following nurses for their work on this project: Kristen Hains, Steve Rutkowski, Hanna Bare, Melanie Cohen, Zoe Gearing, Kyong Golden, James Gonzales, Christina Lai, Brynn Puller, Wendy Wen.
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Research reported in this publication was supported by the Brager Humanitarian Award at the Johns Hopkins Kimmel Cancer Center and an Under Armour Women’s Health & Breast Cancer Innovation Grant, Johns Hopkins Medicine. Funding sources were not involved in the preparation, writing, or submission of this paper.
ORCID iD: Nada Lukkahatai https://orcid.org/0000-0003-3820-1812
The authors affirm that all relevant data supporting the findings of this study are available within the manuscript. Additionally, upon reasonable request, and subject to any necessary permissions and compliance with applicable regulations, the authors will provide access to the raw data used during the research process. This is to ensure transparency and facilitate further scientific inquiry and validation. Interested researchers may contact the corresponding author to inquire about data availability and access.
References
1 Pandey D Lam K Cheung W , et al . Prevalence of psychological symptoms in community-dwelling Chinese American patients with chronic cancer pain . J Immigr Minor Health . 2021 ; 23 : 707 - 716 . doi: 10.1007/s10903-021-01148-0 33527214
2 Gallaway MS Townsend JS Shelby D Puckett MC. Pain among cancer survivors . Prev Chronic Dis . 2020 ; 17 :E54. doi: 10.5888/pcd17.190367 PMC7367076 32644924
3 Copenhaver DJ Huang M Singh J Fishman SM. History and epidemiology of cancer pain . Cancer Treat Res . 2021 ; 182 : 3 - 15 . doi: 10.1007/978-3-030-81526-4_1 34542872
4 Sanford NN Sher DJ Butler SS , et al . Prevalence of chronic pain among cancer survivors in the United States, 2010-2017 . Cancer . 2019 ; 125 : 4310 - 4318 . doi: 10.1002/cncr.32450 31436323
5 Caterino JM Adler D Durham DD , et al . Analysis of diagnoses, symptoms, medications, and admissions among patients with ancer presenting to emergency departments . JAMA Netw Open . 2019 ; 2 :e190979. doi: 10.1001/jamanetworkopen.2019.0979 PMC6583275 30901049
6 Rocque GB Barnett AE Illig LC , et al . Inpatient hospitalization of oncology patients: are we missing an opportunity for end-of-life care? J Oncol Pract . 2013 ; 9 : 51 - 54 . doi: 10.1200/jop.2012.000698 23633971 PMC3545663
7 Paice JA Portenoy R Lacchetti C , et al . Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline . J Clin Oncol . 2016 ; 34 : 3325 - 3345 . doi: 10.1200/jco.2016.68.5206 27458286
8 Greenlee H DuPont-Reyes MJ Balneaves LG , et al . Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment . CA Cancer J Clin . 2017 ; 67 : 194 - 232 . doi: 10.3322/caac.21397 28436999 PMC5892208
9 National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines): adult cancer pain verion 1 . 2020 . Accessed November 20, 2020 . https://www.nccn.org/professionals/physician_gls/pdf/pain.pdf
10 Skelly AC Chou R Dettori JR , et al . AHRQ Comparative Effectiveness Reviews. Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review Update . Agency for Healthcare Research and Quality (US) ; 2020 . 32338846
11 Oliveira CB Maher CG Pinto RZ , et al . Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview . Eur Spine J . 2018 ; 27 : 2791 - 2803 . doi: 10.1007/s00586-018-5673-2 29971708
12 Centers for Medicare and Medicaid Services. Decision memo for acupuncture for chronic low back pain (CAG-00452N) . 2023 . https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=295
13 Nogier R. How did Paul Nogier establish the map of the ear? Med Acupunct . 2014 ; 26 : 76 - 83 .
14 Oleson T. Auriculotherapy Manual: Chinese and Western Systems of Ear Acupuncture . 4th ed. Churchill Livingstone, Elsevier ; 2014 .
15 Nogier P. Handbook to Auriculotherapy . 1st ed . Maisonneuve ; 1981 .
16 Niemtzow R Baxter J Gallagher RM , et al . Building capacity for complementary and integrative medicine through a large, cross-agency, acupuncture training program: lessons learned from a military health system and veterans health administration joint initiative project . Mil Med . 2018 ; 183 :e486-e493. doi: 10.1093/milmed/usy028 29590483
17 Cui J Wang S Ren J Zhang J Jing J. Use of acupuncture in the USA: changes over a decade (2002–2012) . Acupunct Med . 2017 ; 35 : 200 - 207 . doi: 10.1136/acupmed-2016-011106 28087523
18 Ledford CJW Fisher CL Moss DA Crawford PF 3rd . Critical factors to practicing medical acupuncture in family medicine: patient and physician perspectives . J Am Board Fam Med . 2018 ; 31 : 236 - 242 . doi: 10.3122/jabfm.2018.02.170381 29535240
19 Yeh CH Lin WC Suen LKP , et al . Auricular point acupressure to manage arthralgia related to aromatase inhibitors in breast cancer survivors . Oncol Nurs Forum . 2017 ; 44 : 476 - 487 . 28632237 10.1188/17.ONF.476-487
20 Yeh CH Chien LC van Londen G Bovbjerg DH. Auricular point acupressure (APA) to manage a symptom cluster of pain, fatigue, and disturbed sleep in breast cancer patients: a pilot study . J Pain Relief . 2015 ; 4 : 199 . 10.1097/NCC.0000000000000303 26390073
21 Yeh CH Huang L. Comprehensive and systematic auricular diagnosis protocol . Med Acupunct . 2013 ; 25 : 423 - 436 .
22 Yeh CH Huang L Suen LKP . The application of a comprehensive and systematic auricular diagnosis for musculoskeletal system disorder: a treatment protocol for chronic low back pain . Med Acupunct . 2014 ; 26 : 148 - 153 .
23 Zhong Q Wang D Bai YM Du SZ Song YL Zhu J. Effectiveness of auricular acupressure for acute postoperative pain after surgery: a systematic review and meta-analysis . Chin J Integr Med . 2019 ; 25 : 225 - 232 . doi: 10.1007/s11655-019-3063-1 30815805
24 Yang Y Wen J Hong J. The effects of auricular therapy for cancer pain: a systematic review and meta-analysis . Evid Based Complement Alternat Med . 2020 ; 2020 : 1618767 . doi: 10.1155/2020/1618767 32565846 PMC7267873
25 Kim SK Park H. The effect of Auricular Acupressure for chronic low back pain in elders: A randomized controlled study . Holist Nurs Pract . 2021 ; 35 : 182 - 190 . doi: 10.1097/hnp.0000000000000457 34115736
26 Lim Y Park H. The effects of auricular acupressure on low back pain, neuropathy and sleep in patients with persistent spinal pain syndrome (PSPS): a single-blind, randomized placebo-controlled trial . Int J Environ Res Public Health . 2023 ; 20 : 1705 . 36767071 10.3390/ijerph20031705 PMC9913948
27 Yeh CH Caswell K Pandiri S , et al . Dynamic brain activity following auricular point acupressure in chemotherapy-induced neuropathy: a pilot longitudinal functional magnetic resonance imaging study . Glob Adv Health Med . 2020 ; 9 : 1 - 9 . 10.1177/2164956120906092 PMC7019394 32110475
28 Lin WC Yeh CH Chien LC Morone NE Glick RM Albers KM. The anti-inflammatory actions of auricular point acupressure for chronic low back pain . Evid Based Complement Alternat Med . 2015 ; 2015 : 1 - 9 . 10.1155/2015/103570 PMC4480805 26170869
29 Yeh CH Lukkahatai N Campbell C , et al . Preliminary effectiveness of auricular point acupressure on chemotherapy-induced neuropathy: part 2 laboratory-assessed and objective outcomes . Pain Manag Nurs . 2019 ; 20 : 623 - 632 . 31204029 10.1016/j.pmn.2019.04.004
30 Yeh CH Lukkahatai N Huang X , et al . Biological correlates of the effects of Auricular Point Acupressure on Pain . Pain Manag Nurs . 2023 ; 24 : 19 - 26 . doi: 10.1016/j.pmn.2022.11.004 36543665 PMC9928890
31 Hamlin AS Robertson TM. Pain and complementary therapies . Crit Care Nurs Clin North Am . 2017 ; 29 : 449 - 460 . doi: 10.1016/j.cnc.2017.08.005 29107307
32 Maindet C Burnod A Minello C George B Allano G Lemaire A. Strategies of complementary and integrative therapies in cancer-related pain-attaining exhaustive cancer pain management . Support Care Cancer . 2019 ; 27 : 3119 - 3132 . doi: 10.1007/s00520-019-04829-7 31076901
33 Grundy SE. The confidence scale: development and psychometric characteristics . Nurse Educ . 1993 ; 18 : 6 - 9 . doi: 10.1097/00006223-199301000-00004 8487987
34 Cleeland CS Ryan KM. Pain assessment: global use of the brief pain inventory . Ann Acad Med Singap . 1994 ; 23 : 129 - 138 . 8080219
35 Dowell D Haegerich TM Chou R. CDC guideline for prescribing opioids for chronic Pain–United States, 2016 . JAMA . 2016 ; 315 : 1624 - 1645 . doi: 10.1001/jama.2016.1464 26977696 PMC6390846
36 Miles MB Huberman AM. Qualitative Data Analysis: An Expanded Sourcebook . 2 ed . Sage Publications ; 1994 .
37 Basch E Deal AM Dueck AC , et al . Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment . JAMA . 2017 ; 318 : 197 - 198 . doi: 10.1001/jama.2017.7156 28586821 PMC5817466
38 Reyes CC Anderson KO Gonzalez CE , et al . Depression and survival outcomes after emergency department cancer pain visits . BMJ Support Palliat Care . 2019 ; 9 :e36. doi: 10.1136/bmjspcare-2018-001533 30171043
39 Kwekkeboom K Zhang Y Campbell T , et al . Randomized controlled trial of a brief cognitive-behavioral strategies intervention for the pain, fatigue, and sleep disturbance symptom cluster in advanced cancer . Psychooncology . 2018 ; 27 : 2761 - 2769 . doi: 10.1002/pon.4883 30189462 PMC6279506
40 Kelleher SA Winger JG Fisher HM , et al . Behavioral cancer pain intervention using videoconferencing and a mobile application for medically underserved patients: rationale, design, and methods of a prospective multisite randomized controlled trial . Contemp Clin Trials . 2021 ; 102 : 106287 . doi: 10.1016/j.cct.2021.106287 PMC8009852 33497833
41 Scarborough BM Smith CB. Optimal pain management for patients with cancer in the modern era . CA Cancer J Clin . 2018 ; 68 : 182 - 196 . doi: 10.3322/caac.21453 29603142 PMC5980731
42 Deng G. Integrative medicine therapies for pain management in cancer patients . Cancer . 2019 ; 25 : 343 - 348 . doi: 10.1097/ppo.0000000000000399 PMC6777858 31567462